Reduced activity of B lymphocytes, recognised by Sysmex XN‐2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019.

The article discusses research which investigated the link between B lymphocyte activity and mortality of patients with coronavirus disease 2019 (COVID-19). Topics explored include the use of the Sysmex XN-2000™ Haematology System to analyze the haematological parameters of COVID-19 patients, the demographic and laboratory data of patients involved in the study, and other predictors of in-hospital COVID-19-related mortality such as age, creatinine, and C-reactive protein.